Smart-Money SignalNeutral · 55/100— Insiders are net sellers over 90 days (-$82K, 1 sale vs 1 buy)
Revenue$238.0K
Net Income-$26.1M
EPS$-0.20
Market Cap$150.8M
Price Performance
Historical data including institutional events
Company Profile
J
Joseph Oliveto
CEO & Executive Director
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR).
It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil.
Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
